Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 29323.30 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.
Financials
The company’s top management includes Mr.K Ragunathan, Mr.K Nithyananda Reddy, Mr.P Sarath Chandra Reddy, Dr.M Sivakumaran, Mr.M Madan Mohan Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan, Mr.Girish P Vanvari, Dr.(Mrs.)Avnit Bimal Singh. Company has BSR & Associates LLP as its auditors. As on 31-12-2022, the company has a total of 59 Crore shares outstanding.
Investment Rationale
Breakout above its falling 200 DMA after a gap of two years adding to the bullish conviction.
Promoter/FII Holdings
Promoters held 51.83 per cent stake in the company as of 31-Dec-2022, while FIIs owned 22.31 per cent, DIIs 14.9 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price